Overview of Dr. Jelinek
Dr. Michael Jelinek is an oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Rush Oak Park Hospital. He received his medical degree from Rush Medical College and completed his residency and fellowship and University of Chicago. He specializes in head & neck cancer and thoracic cancer.
Office
1725 W. Harrison St
Suite 809
Chicago, IL 60612
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2016 - 2019- University of ChicagoResidency, Internal Medicine, 2013 - 2016
Rush Medical College of Rush University Medical CenterClass of 2013
Certifications & Licensure
IL State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of EP0031 in Patients With Advanced RET-altered Malignancies Start of enrollment: 2022 Sep 30
Roles: Contact
Publications & Presentations
PubMed
- Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized C...Ari J Rosenberg, Aditya Juloori, Michael J Jelinek, Nishant Agrawal, John F Cursio
JAMA Oncology. 2025-03-06 - 1 citationsRadiation Therapy in the Management of Head and Neck Mucosal Melanoma.Omar Azem, Omar Nabulsi, Michael Jelinek, Nikhil Joshi
Cancers. 2024-09-27 - Off the Top of Our Head.Michael J Jelinek, Nikhil Joshi
International Journal of Radiation Oncology, Biology, Physics. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
